What is the scheduling classification for Suboxone, which contains buprenorphine and naloxone?

Suboxone, which is a combination of buprenorphine and naloxone, is classified as a Schedule III substance. This classification is important as it indicates that the substance has a recognized medical use but also carries a potential for abuse that may lead to moderate or low physical dependence or high psychological dependence.

Buprenorphine is an opioid that is used in the treatment of opioid addiction, and it has specific properties that differentiate it from more addictive opioids like those classified as Schedule II. The inclusion of naloxone in Suboxone is intended to mitigate the potential for abuse by blocking the effects of opioids if the product is misused.

The scheduling thus reflects a balance between its medical utility in managing opioid dependence and the regulation necessary to prevent misuse. Understanding this classification helps in recognizing the legal limitations and requirements surrounding prescribing and dispensing Suboxone in Ohio and other jurisdictions.